高龄人群中近视性黄斑病变的患病率:乌拉尔高龄研究
基于人群的乌拉尔高龄研究纳入930名≥85岁可评估眼底像者,近视性黄斑变性(MMD)3期和4期总患病率为2.3%。MMD患病率随眼轴延长而升高,高度近视眼(眼轴≥26.5 mm)中右眼为78%、左眼为75%。多因素分析显示眼轴每增加1 mm,MMD患病风险增加8.89倍。
要点
- ≥85岁可评估眼底像人群中,MMD 3期和4期总患病率为2.3%。
- 高度近视眼(眼轴≥26.5 mm)中MMD患病率右眼78%、左眼75%。
- 多因素分析示眼轴每增加1 mm,MMD患病比值比为8.89。
核心结论
- 高龄人群中MMD(3期和4期)患病率随眼轴每增加1 mm增加8.89倍,高度近视眼患病率≥75%。
- 高龄高度近视个体最终发生伴明显视力损害的MMD风险高。
研究设计与样本
- 基于人群的乌拉尔高龄研究(UVOS)纳入1882名≥85岁合格居民中的1526名(81.1%)。
- 930名(60.9%)个体有可评估眼底像,平均年龄88.6±2.7岁。
- MMD定义为黄斑斑块状萎缩,即病理近视研究组定义的MMD 3期和4期。
主要发现
- MMD总患病率为21/930(2.3%;95%CI 1.3-3.3),其中3期为10人(1.1%;95%CI 0.4-1.7),4期为11人(1.2%;95%CI 0.5-1.9)。
- MMD 3期患者双眼中度至重度视力损害患病率为4/10(40%;95%CI 31-77),4期为7/11(64%;95%CI 30-98)。
- MMD 3期患者双眼盲患病率为2/10(20%;95%CI 0-50),4期为3/11(27%;95%CI 0-59)。
- 右眼MMD患病率在轻度近视(眼轴24.0至<24.5 mm)为0/46(0%),中度近视(24.5至<26.5 mm)为3/40(8%;95%CI 0-16),高度近视(≥26.5 mm)为7/9(78%;95%CI 44-100)。
- 左眼MMD患病率在轻度近视为1/48(2%;95%CI 0-6),中度近视为4/36(11%;95%CI 0-22),高度近视为3/4(75%;95%CI 0-100)。
关键数值与推荐
- MMD定义采用病理近视研究组的MMD 3期和4期标准,即黄斑斑块状萎缩。
- 多因素分析中,较高MMD患病率与较长眼轴相关(比值比8.89;95%CI 3.43-23.0;P<0.001),较高MMD分期也与较长眼轴相关(beta 0.45;B 19;95%CI 0.16-0.22;P<0.001),与其他任何眼部或全身参数无关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the prevalence of myopic macular degeneration (MMD) in very old individuals. METHODS: The population-based Ural Very Old Study (UVOS) included 1526 (81.1%) of 1882 eligible inhabitants aged ≥85 years. Assessable fundus images were available for 930 (60.9%) individuals (mean age, 88.6 ± 2.7 years). MMD was defined by macular patchy atrophies (i.e., MMD stage 3 and 4 as defined by the Pathologic Myopia Study Group). RESULTS: MMD prevalence was 21 of 930 (2.3%; 95% CI, 1.3-3.3), with 10 individuals (1.1%; 95% CI, 0.4-1.7) having MMD stage 3 and 11 participants (1.2%; 95% CI, 0.5-1.9) MMD stage 4 disease. Within MMD stage 3 and 4, prevalence of binocular moderate to severe vision impairment was 4 of 10 (40%; 95% CI, 31-77) and 7 of 11 (64%; 95% CI, 30-98), respectively, and the prevalence of binocular blindness was 2 of 10 (20%; 95% CI, 0-50) and 3 of 11 (27%; 95% CI, 0-59), respectively. In minor myopia (axial length, 24.0 to <24.5 mm), moderate myopia (axial length, 24.5 to <26.5 mm), and high myopia (axial length, ≥26.5 mm), MMD prevalence in the right eyes was 0 of 46 eyes (0%), 3 of 40 eyes (8%; 95% CI, 0-16), and 7 of 9 (78%; 95% CI, 44-100), respectively; MMD prevalence in the left eyes was 1 in 48 eyes (2%; 95% CI, 0-6), 4 of 36 eyes (11%; 95% CI, 0-22), and 3 of 4 eyes (75%; 95% CI, 0-100), respectively. In multivariable analysis, a higher MMD prevalence (odds ratio, 8.89; 95% CI, 3.43-23.0; P < 0.001) and higher MMD stage (beta, 0.45; B, 19; 95% CI, 0.16-0.22; P < 0.001) were correlated with longer axial length but not with any other ocular or systemic parameter. CONCLUSIONS: MMD prevalence (stages 3 and 4) in very old individuals increased 8.89-fold for each mm axial length increase, with a prevalence of ≥75% in highly myopic eyes. In old age, highly myopic individuals have a high risk of eventually developing MMD with marked vision impairment.
引用
- Bikbov MM, Gilmanshin TR, Kazakbaeva GM, et al. Prevalence of Myopic Maculopathy Among the Very Old: The Ural Very Old Study. Invest Ophthalmol Vis Sci. 2024. PMID: 38512243. doi:10.1167/iovs.65.3.29
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。